IP Verse

Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase

Patent No. EP3626258 (titled "Methods And Compositions For Cns Delivery Of Iduronate-2-Sulfatase") was filed by Shire Human Genetic Therapies on Jun 25, 2011. The application was issued on Aug 4, 2021.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
GREEN CROSSMay 3, 2022HGF

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3626258

SHIRE HUMAN GENETIC THERAPIES
Application Number
EP19192679A
Filing Date
Jun 25, 2011
Status
Revoked
Sep 25, 2025
Publication Date
Aug 4, 2021
External Links
Slate, Register , Google Patents